163 related articles for article (PubMed ID: 10611747)
1. T lymphocyte-dependent effector mechanisms of immunity to Toxoplasma gondii.
Denkers EY
Microbes Infect; 1999 Jul; 1(9):699-708. PubMed ID: 10611747
[TBL] [Abstract][Full Text] [Related]
2. T cell-derived interferon-γ is required for host defense to Toxoplasma gondii.
Nishiyama S; Pradipta A; Ma JS; Sasai M; Yamamoto M
Parasitol Int; 2020 Apr; 75():102049. PubMed ID: 31901434
[TBL] [Abstract][Full Text] [Related]
3. TLR11-independent inflammasome activation is critical for CD4+ T cell-derived IFN-γ production and host resistance to Toxoplasma gondii.
López-Yglesias AH; Camanzo E; Martin AT; Araujo AM; Yarovinsky F
PLoS Pathog; 2019 Jun; 15(6):e1007872. PubMed ID: 31194844
[TBL] [Abstract][Full Text] [Related]
4. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
Caamaño J; Tato C; Cai G; Villegas EN; Speirs K; Craig L; Alexander J; Hunter CA
J Immunol; 2000 Nov; 165(10):5720-8. PubMed ID: 11067930
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function.
Yap GS; Sher A
Immunobiology; 1999 Dec; 201(2):240-7. PubMed ID: 10631573
[TBL] [Abstract][Full Text] [Related]
6. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.
Cai G; Radzanowski T; Villegas EN; Kastelein R; Hunter CA
J Immunol; 2000 Sep; 165(5):2619-27. PubMed ID: 10946290
[TBL] [Abstract][Full Text] [Related]
7. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.
Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.
Scharton-Kersten T; Caspar P; Sher A; Denkers EY
Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760
[TBL] [Abstract][Full Text] [Related]
9. Downmodulation of Effector Functions in NK Cells upon Toxoplasma gondii Infection.
Sultana MA; Du A; Carow B; Angbjär CM; Weidner JM; Kanatani S; Fuks JM; Muliaditan T; James J; Mansfield IO; Campbell TM; Liu L; Kadri N; Lambert H; Barragan A; Chambers BJ
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760930
[TBL] [Abstract][Full Text] [Related]
10. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
Deckert-Schlüter M
Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
[TBL] [Abstract][Full Text] [Related]
11. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.
Wilson DC; Matthews S; Yap GS
J Immunol; 2008 May; 180(9):5935-45. PubMed ID: 18424713
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and lymphocyte profiles in miniature swine after oral infection with Toxoplasma gondii oocysts.
Solano Aguilar GI; Beshah E; Vengroski KG; Zarlenga D; Jauregui L; Cosio M; Douglass LW; Dubey JP; Lunney JK
Int J Parasitol; 2001 Feb; 31(2):187-95. PubMed ID: 11239939
[TBL] [Abstract][Full Text] [Related]
13. Cutting Edge: IFN-γ Produced by Brain-Resident Cells Is Crucial To Control Cerebral Infection with Toxoplasma gondii.
Sa Q; Ochiai E; Tiwari A; Perkins S; Mullins J; Gehman M; Huckle W; Eyestone WH; Saunders TL; Shelton BJ; Suzuki Y
J Immunol; 2015 Aug; 195(3):796-800. PubMed ID: 26091720
[TBL] [Abstract][Full Text] [Related]
14. T cell expression of MyD88 is required for resistance to Toxoplasma gondii.
LaRosa DF; Stumhofer JS; Gelman AE; Rahman AH; Taylor DK; Hunter CA; Turka LA
Proc Natl Acad Sci U S A; 2008 Mar; 105(10):3855-60. PubMed ID: 18308927
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii.
Tato CM; Villarino A; Caamaño JH; Boothby M; Hunter CA
J Immunol; 2003 Mar; 170(6):3139-46. PubMed ID: 12626571
[TBL] [Abstract][Full Text] [Related]
16. Strain- and Dose-Dependent Reduction of
Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
[No Abstract] [Full Text] [Related]
17. A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii.
Villegas EN; Lieberman LA; Mason N; Blass SL; Zediak VP; Peach R; Horan T; Yoshinaga S; Hunter CA
J Immunol; 2002 Jul; 169(2):937-43. PubMed ID: 12097399
[TBL] [Abstract][Full Text] [Related]
18. STAT1 is essential for antimicrobial effector function but dispensable for gamma interferon production during Toxoplasma gondii infection.
Gavrilescu LC; Butcher BA; Del Rio L; Taylor GA; Denkers EY
Infect Immun; 2004 Mar; 72(3):1257-64. PubMed ID: 14977926
[TBL] [Abstract][Full Text] [Related]
19. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
Yap GS; Sher A
J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
[TBL] [Abstract][Full Text] [Related]
20. Protection against lethal toxoplasmosis in mice by an avirulent strain of Toxoplasma gondii: stimulation of IFN-gamma and TNF-alpha response.
Haque S; Franck J; Dumon H; Kasper LH; Haque A
Exp Parasitol; 1999 Dec; 93(4):231-40. PubMed ID: 10600449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
